Walleye Trading’s 10x Genomics TXG Stock Holding History

Walleye Trading’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,900	Closed	-$597K	–	4925
2024 Q1	$597K	Buy	15,900 +4,900	+45%	+$215K	﹤0.01%	2646
2023 Q4	$616K	Sell	11,000 -109,200	-91%	-$4.75M	﹤0.01%	2896
2023 Q3	$4.96M	Buy	120,200 +107,100	+818%	+$5.57M	0.01%	1133
2023 Q2	$732K	Sell	13,100 -14,800	-53%	-$801K	﹤0.01%	2448
2023 Q1	$1.56M	Buy	27,900 +20,800	+293%	+$971K	﹤0.01%	1858
2022 Q4	$259K	Buy	+7,100	New	+$232K	﹤0.01%	3371
2022 Q2	–	Sell	-6,200	Closed	-$472K	–	5679
2022 Q1	$472K	Buy	+6,200	New	+$542K	﹤0.01%	2971
2021 Q3	–	Sell	-6,400	Closed	-$1.25M	–	5740
2021 Q2	$1.25M	Buy	6,400 +5,400	+540%	+$977K	﹤0.01%	1908
2021 Q1	$181K	Sell	1,000 -4,000	-80%	-$691K	﹤0.01%	3724
2020 Q4	$708K	Sell	5,000 -2,300	-32%	-$334K	﹤0.01%	2346
2020 Q3	$910K	Buy	+7,300	New	+$766K	﹤0.01%	1731

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Walleye Trading's TXG Position: Q4 2023 in Review

Walleye Trading sold out of 10x Genomics (TXG) in Q4 2023, closing a stake of 36,868 shares — an estimated $1.6M sold.

Walleye Trading first reported a position in TXG in Q3 2020 and held it in 7 quarters. The position peaked at $1.52M in Q3 2023. 275 funds tracked by Wall St. Rank hold TXG as of Q4 2023.

Walleye Trading reported no remaining 10x Genomics position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 36,868 10x Genomics shares in Q4 2023, an estimated $1.6M.
Walleye Trading first reported a position in 10x Genomics in Q3 2020 and held it in 7 quarters.
Walleye Trading's 10x Genomics position peaked at $1.52M in Q3 2023.
275 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.